|
|
New FREEDOM Data Adds to Compelling Evidence in Support of More Frequent Home ... - Sacramento Bee |
 |
 |
Sacramento Bee
In addition, patients who had received more frequent dialysis with the System One for 12 months were clearly motivated and unlikely to consider returning to their prior dialysis modality. The ongoing FREEDOM study is the largest study of its kind to
|
|
|
ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical ... - BioMedReports (subscription) |
|
|
BioMedReports (subscription)
By PR Newswire: Biotechnology CCR2 inhibition in diabetic mice resulted in rapid and robust improvements of albuminuria, serum markers of renal function, and hyperglycemia. These data were highlighted today in a poster presentation titled "CCR2 ...
ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical
|
|
DaVita to Present 11 Abstracts at the American Society of Nephrology's Kidney ... - MarketWatch (press release) |
|
|
MarketWatch (press release)
ASN's Kidney Week is the world's premier nephrology meeting and serves as a platform for more than 13000 kidney professionals from around the globe to exchange knowledge, learn the latest scientific and medical advances, and listen to leading experts
|
|
|
NxStage Medical, Inc. : New FREEDOM Data Adds to Compelling Evidence in ... - 4-traders (press release) |
|
|
4-traders (press release)
(Index: P=0.002) Michael A Kraus, MD, Medical Director, Professor of Clinical Medicine and Clinical Coordinator, Division of Nephrology, Indiana University School of Medicine and Clarian Health Partners and presenter of the FREEDOM study data at Kidney ...
NxStage Applauds Presentation of Study on Piperacillin Use During Continuous
|
|
ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical ... - MarketWatch (press release) |
|
|
MarketWatch (press release)
10, 2011 /PRNewswire via COMTEX/ -- ChemoCentryx, Inc. today announced positive preclinical results for its novel CCR2 antagonist at the 44th Annual Meeting of the American Society of Nephrology. CCR2 inhibition in diabetic mice resulted in rapid and
|
|
|
|
|
<< Start < Prev 591 592 593 594 595 596 597 598 599 600 Next > End >>
|
|
Page 596 of 2630 |
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
